MedSource Labs Announces Groundbreaking Digital Training Assets for IV Catheters 7-11-2024, 20:00

FloQast chosen by Halfords to streamline compliance and prepare for Provision 29 9-10-2025, 14:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00